Healthcare >> CEO Interviews >> October 26, 2004

William Dow – Aksys Ltd (aksy)

WILLIAM C. DOW is President and Chief Executive Officer of Aksys, Ltd. He joined the company in October 1999. Since that time, he has directed the company through the clinical trial for the Aksys Personal Hemodialysis System (PHD'), obtained FDA approval to market the product, raised over $100 million in additional capital for the company, and restructured the organization for commercialization. Before joining Aksys, he was President and CEO of PLC Systems, a pioneer in the development of products used to perform transmyocardial revascularization (TMR), a medical treatment for patients suffering from coronary artery disease. Prior to PLC, he served as President and CEO of Deknatel Snowden Pencer, a medical device manufacturer of surgical products, which was acquired in July 1996 by Genzyme, a Cambridge, Massachusetts-based biotechnology company. Mr. Dow joined Deknatel in 1993 and led a turnaround that produced a sales growth of over 20% and a doubling of operating profits. He has almost 30 years of experience in the medical device industry, having held various positions in sales, marketing, distribution and general management with such companies as American Hospital Supply, Terumo, and Kendall. Mr. Dow is a graduate of the United States Naval Academy. Profile
TWST: Please give us an overview of Aksys.

Mr. Dow: Rod Kenley founded Aksys in the early 1990s. Rod had been at

Baxter working in their renal division and he had come across the

concept of